These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 32317164)

  • 1. [Clozapine prescription in the wake of the coronavirus (SARS CoV-2) outbreak: What measures? Why?].
    Ben Dhia A; Hamzaoui S; Mouaffak F
    Encephale; 2020 Jun; 46(3S):S123-S124. PubMed ID: 32317164
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thoughts on a favourable evolution of a COVID-19 in a patient with resistant schizophrenia and on a combination of clozapine and paliperidone palmitate].
    Bouaziz N; Ben Rejeb H; Ateb S; Fourati T; Chammas F; Baha D; Rosetti R; Kalalou K; Saba G; Benadhira R; Januel D
    Encephale; 2020 Jun; 46(3S):S126-S127. PubMed ID: 32475694
    [No Abstract]   [Full Text] [Related]  

  • 3. Clozapine Toxicity in the Setting of COVID-19.
    Dotson S; Hartvigsen N; Wesner T; Carbary TJ; Fricchione G; Freudenreich O
    Psychosomatics; 2020; 61(5):577-578. PubMed ID: 32593477
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-convulsive status epilepticus: COVID-19 or clozapine induced?
    Sokolov E; Hadavi S; Mantoan Ritter L; Brunnhuber F
    BMJ Case Rep; 2020 Oct; 13(10):. PubMed ID: 33012721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus statement on the use of clozapine during the COVID-19 pandemic.
    Siskind D; Honer WG; Clark S; Correll CU; Hasan A; Howes O; Kane JM; Kelly DL; Laitman R; Lee J; MacCabe JH; Myles N; Nielsen J; Schulte PF; Taylor D; Verdoux H; Wheeler A; Freudenreich O
    J Psychiatry Neurosci; 2020 May; 45(3):222-223. PubMed ID: 32297722
    [No Abstract]   [Full Text] [Related]  

  • 6. The Risks of Prescribing Hydroxychloroquine in COVID-19-Infected Patients With Schizophrenia.
    Uvais NA
    Prim Care Companion CNS Disord; 2020 Apr; 22(3):. PubMed ID: 32369686
    [No Abstract]   [Full Text] [Related]  

  • 7. Reactive Psychosis in a Health Care Worker During the COVID-19 Pandemic.
    Rivas VCMO; Hernández-Huerta D; Silva CPD; Gómez-Arnau J
    Prim Care Companion CNS Disord; 2020 Jul; 22(4):. PubMed ID: 32649065
    [No Abstract]   [Full Text] [Related]  

  • 8. Command Suicidal Hallucination as Initial Presentation of Coronavirus Disease 2019 (COVID-19): A Case Report.
    Mirza J; Ganguly A; Ostrovskaya A; Tusher A; Viswanathan R
    Psychosomatics; 2020; 61(5):561-564. PubMed ID: 32593478
    [No Abstract]   [Full Text] [Related]  

  • 9. Antipsychotic prescribing to people with dementia during COVID-19.
    Howard R; Burns A; Schneider L
    Lancet Neurol; 2020 Nov; 19(11):892. PubMed ID: 33098796
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychosis Treatment During COVID-19 Pandemic and the Potential Role of Phenothiazines: A Call for Research Studies.
    Ruiz de Pellón Santamaría Á
    J Clin Psychopharmacol; 2020; 40(6):641-642. PubMed ID: 33136928
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors.
    Wu Q; Chu Q; Zhang H; Yang B; He X; Zhong Y; Yuan X; Chua MLK; Xie C
    Cancer Commun (Lond); 2020 Aug; 40(8):374-379. PubMed ID: 32666636
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuroleptic malignant syndrome in a COVID-19 patient.
    Kajani R; Apramian A; Vega A; Ubhayakar N; Xu P; Liu A
    Brain Behav Immun; 2020 Aug; 88():28-29. PubMed ID: 32425332
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 Psychosis: A Potential New Neuropsychiatric Condition Triggered by Novel Coronavirus Infection and the Inflammatory Response?
    Ferrando SJ; Klepacz L; Lynch S; Tavakkoli M; Dornbush R; Baharani R; Smolin Y; Bartell A
    Psychosomatics; 2020; 61(5):551-555. PubMed ID: 32593479
    [No Abstract]   [Full Text] [Related]  

  • 14. [Is there a need for ophthalmological surveillance in the case of short-term hydroxychloroquine treatment during this COVID-19 pandemic?].
    Defoort-Dhellemmes S
    J Fr Ophtalmol; 2020 Jun; 43(6):548-549. PubMed ID: 32451138
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19 as a cause of immune thrombocytopenia.
    Humbert S; Razanamahery J; Payet-Revest C; Bouiller K; Chirouze C
    Med Mal Infect; 2020 Aug; 50(5):459-460. PubMed ID: 32445664
    [No Abstract]   [Full Text] [Related]  

  • 16. Covid-19: The last call for telepsychiatry.
    Amerio A; Odone A; Marzano L; Costanza A; Aguglia A; Serafini G; Signorelli C; Ghaemi SN; Amore M
    Acta Biomed; 2020 Jul; 91(3):ahead of print. PubMed ID: 32921742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orthopaedic Considerations Following COVID-19: Lessons from the 2003 SARS Outbreak.
    Patel MS; Gutman MJ; Abboud JA
    JBJS Rev; 2020 Jul; 8(7):e2000052. PubMed ID: 32759612
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19: Small-Molecule Clinical Trials Landscape.
    Ferreira LLG; Andricopulo AD
    Curr Top Med Chem; 2020; 20(18):1577-1580. PubMed ID: 32862824
    [No Abstract]   [Full Text] [Related]  

  • 19. Secondary hemophagocytic lymphohistiocytosis, HScore and COVID-19.
    Loscocco GG
    Int J Hematol; 2020 Jul; 112(1):125-126. PubMed ID: 32474804
    [No Abstract]   [Full Text] [Related]  

  • 20. Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19.
    Takami A
    Int J Hematol; 2020 Jul; 112(1):122-124. PubMed ID: 32399895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.